Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim E de Roode

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of RadioligandsKim E de Roode, Lieke Joosten, Martin Behe
Topics in Current Chemistry (Cham)|March 5, 2025
Toward Realization of Bioorthogonal Chemistry in the ClinicKim E de Roode, Raffaella Rossin, Marc S Robillard
Small (Weinheim an Der Bergstrasse, Germany)|May 3, 2024
Tumor-On-A-Chip Models for Predicting In Vivo Nanoparticle BehaviorKim E de Roode, Khadijeh Hashemi, Wouter P R Verdurmen, et al.
Theranostics|August 9, 2023
Click-to-Release: Cleavable Radioimmunoimaging with [<sup>89</sup>Zr]Zr-DFO-<i>Trans</i>-Cyclooctene-Trastuzumab Increases Tumor-to-Blood RatioMaria Vlastara, Raffaella Rossin, Freek J M Hoeben, et al.
Bioconjugate Chemistry|December 27, 2021
Strain-Promoted Azide-Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate CancerYvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 ProdrugMartijn H den Brok, Kim E de Roode, Luc H M Zijlmans, et al.
Nature Biomedical Engineering|April 9, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloadsAngela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of RadioligandsKim E de Roode, Lieke Joosten, Martin Behe
Topics in Current Chemistry (Cham)|March 5, 2025
Toward Realization of Bioorthogonal Chemistry in the ClinicKim E de Roode, Raffaella Rossin, Marc S Robillard
Small (Weinheim an Der Bergstrasse, Germany)|May 3, 2024
Tumor-On-A-Chip Models for Predicting In Vivo Nanoparticle BehaviorKim E de Roode, Khadijeh Hashemi, Wouter P R Verdurmen, et al.
Theranostics|August 9, 2023
Click-to-Release: Cleavable Radioimmunoimaging with [<sup>89</sup>Zr]Zr-DFO-<i>Trans</i>-Cyclooctene-Trastuzumab Increases Tumor-to-Blood RatioMaria Vlastara, Raffaella Rossin, Freek J M Hoeben, et al.
Bioconjugate Chemistry|December 27, 2021
Strain-Promoted Azide-Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate CancerYvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 ProdrugMartijn H den Brok, Kim E de Roode, Luc H M Zijlmans, et al.
Nature Biomedical Engineering|April 9, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloadsAngela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall, et al.
Pageof 1